| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040872171 |
| P356 | DOI | 10.1007/BF03349761 |
| P698 | PubMed publication ID | 9221268 |
| P2093 | author name string | R D Gordon | |
| P2860 | cites work | Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase | Q28208090 |
| Genetic aspects of adenomatosis of endocrine glands | Q34234754 | ||
| Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle | Q34558202 | ||
| Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity | Q35578995 | ||
| Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone | Q35918455 | ||
| Integrated imaging of adrenal disease | Q36223525 | ||
| Commentary on incidence of primary aldosteronism: current estimations based on objective data | Q36534404 | ||
| Severe hypokalaemia with paralysis induced by small doses of liquorice | Q36716153 | ||
| Hormonal evaluation of the patient with an incidentally discovered adrenal mass | Q37984464 | ||
| Severe hypertension in primary aldosteronism and good response to surgery | Q39534746 | ||
| A Syndrome of Apparent Mineralocorticoid Excess Associated with Defects in the Peripheral Metabolism of Cortisol* | Q40260133 | ||
| Primary aldosteronism--some genetic, morphological, and biochemical aspects of subtypes | Q40551412 | ||
| Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans | Q41393970 | ||
| Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus | Q42462251 | ||
| Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas) | Q42494056 | ||
| Spectrum of mineralocorticoid hypertension | Q43555317 | ||
| Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria | Q43891164 | ||
| Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity | Q44402745 | ||
| Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism | Q44755161 | ||
| Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension | Q45186705 | ||
| Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. | Q54394511 | ||
| A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension | Q55671192 | ||
| Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers | Q56974748 | ||
| THE DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM | Q57740992 | ||
| Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1 | Q67518300 | ||
| Primary aldosteronism: hypertension with a genetic basis | Q67518433 | ||
| Incidentally discovered adrenal tumors: an institutional perspective | Q67768839 | ||
| The evolution of primary aldosteronism: 1954-1967 | Q68581069 | ||
| Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism | Q68920989 | ||
| Anomalous Postural Response of Plasma Aldosterone Concentration In Patients With Aldosterone-Producing Adrenal Adenoma | Q69470139 | ||
| Possible association of aldosterone producing adenoma and non-functioning adrenal tumor | Q69613832 | ||
| Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension | Q69717583 | ||
| Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis | Q69809130 | ||
| Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension | Q69822297 | ||
| Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? | Q69903900 | ||
| Malignant hypertension due to an aldosterone producing adrenal adenoma | Q69908178 | ||
| Occult ectopic secretion of corticotropin | Q70042087 | ||
| Ectopic ACTH syndrome. Diagnostic and therapeutic aspects | Q70078536 | ||
| A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients | Q70194808 | ||
| Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin | Q70212306 | ||
| Clinical and pathological diversity of primary aldosteronism, including a new familial variety | Q70220702 | ||
| Laparoscopic adrenalectomy for adrenal tumours causing hypertension and for 'incidentalomas' of the adrenal on computerized tomography scanning | Q70952698 | ||
| The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism | Q71480093 | ||
| Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors | Q71680255 | ||
| Hypertension due to a renin-secreting renal tumour | Q72314556 | ||
| A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension | Q72566478 | ||
| Genetics of primary aldosteronism | Q72611689 | ||
| Mineralocorticoid hypertension | Q72684588 | ||
| Surgical Management of the Ectopic ACTH Syndrome | Q72948763 | ||
| Does adrenocortical hyperplasia result in adrenocortical carcinoma | Q74758981 | ||
| A liquorice extract with deoxycortone-like action | Q75544027 | ||
| SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM | Q77152764 | ||
| NORMOKALEMIC PRIMARY ALDOSTERONISM. A DETECTABLE CAUSE OF CURABLE "ESSENTIAL" HYPERTENSION | Q78425474 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 495-511 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | Primary aldosteronism | |
| P478 | volume | 18 |
| Q54857430 | 11-Deoxycortisol may be superior to cortisol in confirming a successful adrenal vein catheterization without cosyntropin: a pilot study. |
| Q90386414 | A case of primary aldosteronism who experienced cardiopulmonary arrest, was resuscitated and cured |
| Q37879448 | A comprehensive review of the clinical aspects of primary aldosteronism |
| Q24681542 | A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22) |
| Q36134787 | A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension |
| Q74463365 | Adrenomedullin levels are high in primary aldosteronism due to adenoma and decline after surgical cure |
| Q38208961 | Aldosterone excess and resistant hypertension: investigation and treatment |
| Q35198525 | Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study |
| Q43624745 | Conn's syndrome and bilateral renal artery stenosis in the presence of multiple renal arteries |
| Q73357188 | Diagnosis and management of primary aldosteronism |
| Q95464571 | Diagnosis and treatment of primary aldosteronism |
| Q37082990 | Differential diagnosis of hyperkalemia: an update to a complex problem |
| Q34981005 | Differential diagnosis of primary aldosteronism subtypes |
| Q81065568 | Familial forms broaden the horizons for primary aldosteronism |
| Q74608992 | Familial hyperaldosteronism |
| Q35173855 | Forms of mineralocorticoid hypertension |
| Q47331060 | High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism. |
| Q46542920 | Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate |
| Q33681792 | Investigation protocol: adrenal enlargement |
| Q33868500 | Laboratory investigation of primary aldosteronism. |
| Q33872503 | Management approaches to adrenal incidentalomas. A view from Ancona, Italy |
| Q35074277 | New aspects on primary aldosteronism |
| Q36794918 | New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism |
| Q36450459 | Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension. |
| Q33983858 | Pathophysiology and diagnosis of primary aldosteronism |
| Q46740951 | Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia |
| Q75196475 | Primary aldosteronism |
| Q34381179 | Primary aldosteronism: are we diagnosing and operating on too few patients? |
| Q37951385 | Primary aldosteronism: from bench to bedside |
| Q35208683 | Primary aldosteronism: from genesis to genetics |
| Q34251358 | Primary aldosteronism: rare bird or common cause of secondary hypertension? |
| Q34755505 | Selected endocrine test strategies |
| Q43148847 | Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism |
| Q45269582 | Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma |
| Q45214441 | Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin |
| Q35989780 | Work-up of the functional adrenal mass |
Search more.